Financials
Financial year 2026
PharmCollab Consultancy from Antwerpen, company number BE1011185210, closed financial year 2026 with a result of € 71,126 after tax. For that financial year PharmCollab Consultancy recorded a gross margin of € 104,258 and equity of € 149,017. Compared with financial year 2025, the result moved from € 75,750 to € 71,126. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 149,017
▲ 91% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 71,126
▼ 6% vs 2025
Profit after tax over the fiscal year.
€ 57,966
▲ 48% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 146,017.
People and assets in 2026
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 32,877
▲ 5% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 16
▼ 92% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 10,567
▼ 46% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|
| Gross margin | € 111,881 | € 104,258 | ▼ 7% |
| Profit after taxes | € 75,750 | € 71,126 | ▼ 6% |
| Equity | € 77,891 | € 149,017 | ▲ 91% |
| Total debts | € 20,764 | € 11,638 | ▼ 44% |
| Cash | € 39,068 | € 57,966 | ▲ 48% |
| Retained profit | € 74,891 | € 146,017 | ▲ 95% |
| Dividend | € 859 | € 0 | ▼ 100% |
| Balance sheet total | € 98,655 | € 160,656 | ▲ 63% |
Key figures of PharmCollab Consultancy, fiscal years 2025 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 30 January 2028.
What happened to PharmCollab Consultancy?
What happened at PharmCollab Consultancy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 71,126 (▼ 6% vs 2025). Source: NBB ↗
- New establishment in Antwerpen. KBO
- Marleen HAEMS became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 75,750 profit in 2025 to € 71,126 profit in 2026.
Paid € 53,453 in corporate taxes since 2025.
Best year ever: 2025, with € 75,750 profit.
Paid out € 859 in dividends to the owners in total.
A new publication or filing at PharmCollab Consultancy? We notify you, reason included.
Follow PharmCollab ConsultancyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PharmCollab Consultancy is Marleen HAEMS.
Directors
According to the 2026 annual accounts
Marleen HAEMS
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Ringlaan 80
2610 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1011.185.210
- VAT number
- BE 1011.185.210
- Registered office
- Ringlaan 80, 2610 Antwerpen
- Names & denominations
- PharmCollab Consultancy
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 July 2024
- Peppol
- Active · Active since 12 Nov 2024
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige zakelijke dienstverlening, neg
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Computerconsultancy-activiteiten
+3